2-Formyl-cyclohexanecarbonitrile | 83268-59-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-Formyl-cyclohexanecarbonitrile
• 英文别名: 2-Formylcyclohexane-1-carbonitrile
• CAS: 83268-59-1
• 化学式: C₈H₁₁NO
• 分子量: 137.181
• InChiKey: FGNRQOHLHIHYET-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  异氰酸叔丁酯 、 1-cyclohexene-1-carboxaldehyde 在 二氯乙基铝 作用下， 以 二氯甲烷 为溶剂， 反应 7.0h， 以74%的产率得到2-Formyl-cyclohexanecarbonitrile
  参考文献：
  名称：

  A novel conjugate hydrocyanation with titanium tetrachloride-tert-butyl isocyanide

  摘要：

  DOI：

  10.1021/ja00387a050

文献信息

• Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation
  申请人：Sankyo Company Limited

  公开号：EP0542411A2

  公开（公告）日：1993-05-19

  Compounds of formula (I): in which: R¹ is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulphonyl, haloalkanesulphonyl or sulphamoyl; R² is optionally substituted alkanoyl, optionally substituted alkenoyl, optionally substituted cycloalkylcarbonyl, substituted benzoyl, or 5,6-dihydro-1,4,2-dioxazin-3-yl; R³ is hydrogen, hydroxy, optionally substituted alkoxy, aralkyloxy, alkanoyloxy, alkenoyloxy, cycloalkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aralkyloxycarbonylxy, phthalidyloxy, (5-methyl-2-oxo-1,3-dioxolen-4-yl)methoxy, (5-phenyl-2-oxo-1,3-dioxolen-4-yl)methoxy, optionally substituted amino or nitro; Y is -NH- or oxygen or sulphur; n is 1 to 5; and tautomers and salts of said compounds of formula (I), have the ability to inhibit blood platelet aggregation, and can thus be used for treatment and prophylaxis of thrombosis and embolisms.

  式(I)化合物： 其中R¹ 是氢、烷基、卤素、卤代烷基、羟基、烷氧基、卤代烷氧基、烷硫基、卤代烷硫基、氨基、烷酰基、卤代烷酰基、羧基、烷氧羰基、氨基甲酰基、氰基、硝基、烷磺酰基、卤代烷磺酰基或磺酰基；R² 是任选取代的烷酰基、任选取代的烯酰基、任选取代的环烷基羰基、取代的苯甲酰基或 5,6-二氢-1,4,2-二恶嗪-3-基；R³ 是氢、羟基、任选取代的烷氧基、烷氧基、烷甲氧基、烯甲氧基、环烷基羰基氧基、芳基羰基氧基、烷氧基羰基氧基、烷氧基羰基氧基、酞酰氧基、(5-甲基-2-氧代-1,3-二氧戊烯-4-基)甲氧基、(5-苯基-2-氧代-1,3-二氧戊烯-4-基)甲氧基、任选取代的氨基或硝基；Y 是-NH-或氧或硫；n 是 1 至 5；所述式（I）化合物的同系物和盐具有抑制血小板聚集的能力，因此可用于血栓和栓塞的治疗和预防。
• CYCLIC AMINO COMPOUNDS
  申请人：Sankyo Company Limited

  公开号：EP1063230A1

  公开（公告）日：2000-12-27

  Cyclic amino compounds represented by general formula (I) or pharmacologically acceptable salts thereof having an excellent antiplatelet aggregation effect; etc. and thus being useful as preventives or remedies for embolism, thrombosis or arterial sclerosis wherein R1 represents optionally substituted phenyl; R2 represents optionally substituted aliphatic acyl, optionally substituted benzoyl or alkoxycarbonyl; and R3 represents substituted and optionally ring-fused saturated cyclic amino.

  通式(I)代表的环状氨基化合物或其药理上可接受的盐，具有优异的抗血小板聚集作用等，因此可作为栓塞、血栓形成或动脉硬化的预防剂或治疗剂 其中R1代表任选取代的苯基；R2代表任选取代的脂肪族酰基、任选取代的苯甲酰基或烷氧基羰基；R3代表取代的和任选环融的饱和环状氨基。
• Treatment of laminitis with platelet aggregation inhibitors
  申请人：Dussler, Sabine

  公开号：EP2497475A1

  公开（公告）日：2012-09-12

  The present invention relates to the novel use of platelet aggregation inhibitors for the treatment and/or prevention of Laminitis in veterinary medicine. In particular the invention refers to the novel use of specific antiplatelet drugs for the treatment and/or prevention of Laminitis.

  本发明涉及在兽医学中使用血小板聚集抑制剂治疗和/或预防蹄叶炎的新方法。特别是，本发明涉及特定抗血小板药物在治疗和/或预防蹄叶炎方面的新用途。
• ITO, YOSHIHIKO;KATO, HIDEHITO;IMAI, HIROSHI;SAEGUSA, TAKEO, J. AMER. CHEM. SOC., 1982, 104, N 23, 6449-6450
  作者：ITO, YOSHIHIKO、KATO, HIDEHITO、IMAI, HIROSHI、SAEGUSA, TAKEO

  DOI：——

  日期：——
• CYCLIC AMINE DERIVATIVES
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0934928B1

  公开（公告）日：2004-10-13